Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

MIA VESELY is a College junior studying philosophy, politics, and economics from Phoenix. Her email is [email protected].

A classic giallo tinged with American slasher influences, Opera has been called the last truly great film of Dario Argento's ...

In this white paper, you will find some real-world definitions of many of the confusing terms thrown around in VFD manuals ...

To imagine an Austin without an Austin Kite Festival is to think of an Austin without Bobby Jenkins' impact. And that's just ...

Infants should sleep alone, on their back and in a crib. Those are the ABCs of sleep being stressed by Children’s Hospital of ...

Should one be a newcomer to the Medicare scene, at first glance, capital letters involved sometimes sound a bit confusing. To ...

A Quiet Place to Kill may not have alien killers who can hear a pin drop, but it does have plenty of sleazy Italians bumping off their wives.

The FDA’s Predetermined Change Control Plans (PCCPs) tool aims to ease the regulatory burden of updating AI/ML algorithms.

Recently, I’ve been looking more and more into closed-end funds, or CEFs, as they complement and further diversify my ...

Now is the time to increase color in next spring’s garden by purchasing spring-flowering bulbs. Consider planting daffodils, ...

The San Francisco 49ers did not hold a practice on Monday but, per NFL rules, released an estimated participation report.